Based on its well-established role in promoting T cell survival, persistence, and metabolic fitness, Interleukin-15 would be predicted to significantly increase the magnitude and sustainability of cytokine release (such as IFN-γ and TNF-α) from CAR T cells upon encountering their target antigen, when compared to CAR T cells manufactured in its absence.